Atherosclerosis
Volume 210, Issue 2 , Pages 344-352 , June 2010

Effects of zinc on plasma lipoprotein cholesterol concentrations in humans: A meta-analysis of randomised controlled trials

  • Meika Foster

      Affiliations

    • Discipline of Nutrition and Metabolism, School of Molecular and Microbial Biosciences, University of Sydney NSW 2006, Australia
    • ,
  • Peter Petocz

      Affiliations

    • Department of Statistics, Macquarie University, NSW 2109, Australia
    • ,
  • Samir Samman

      Affiliations

    • Discipline of Nutrition and Metabolism, School of Molecular and Microbial Biosciences, University of Sydney NSW 2006, Australia
    • Corresponding Author InformationCorresponding author at: Discipline of Nutrition and Metabolism, School of Molecular and Microbial Biosciences, Biochemistry and Microbiology Building, G08, The University of Sydney, NSW 2006, Australia. Tel.: +61 2 9351 2476; fax: +61 2 9351 6022.

Received 13 June 2009 ,Revised 18 November 2009 ,Accepted 24 November 2009.

References 

  1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001; 285:2486-97.
  2. King JC, Cousins RJ. Zinc. In:  Shils ME,  Shike M,  Ross AC,  Caballero B,  Cousins RJ editor. Modern Nutrition in Health and Disease.. 10th ed.. Philadelphia: Lippincott Williams and Wilkins; 2006;p. 271–285
  3. Prasad AS. Discovery of human zinc deficiency and studies in an experimental human model. Am J Clin Nutr. 1991;53:403–412
  4. Cousins RJ, Blanchard RK, Moore JB, et al. Regulation of zinc metabolism and genomic outcomes. J Nutr. 2003;133(Suppl 1):1521S–1526S
  5. Beattie JH, Gordon MJ, Rucklidge GJ, et al. Aorta protein networks in marginal and acute zinc deficiency. Proteomics. 2008;8:2126–2135
  6. Klevay LM. Hypercholesterolemia in rats produced by an increase in the ratio of zinc to copper ingested. Am J Clin Nutr. 1973;26:1060–1068
  7. Hooper PL, Visconti L, Garry PJ, Johnson GE. Zinc lowers high-density lipoprotein cholesterol levels. JAMA. 1980;244:1960–1961
  8. Chandra RK. Excessive intake of zinc impairs immune responses. JAMA. 1984;252:1443–1446
  9. Hughes S, Samman S. The effect of zinc supplementation in humans on plasma lipids, antioxidant status and thrombogenesis. J Am Coll Nutr. 2006;25:285–291
  10. Lindeman RD, Baxter DJ, Yunice AA, King RW, Kraikit S. Zinc metabolism in renal disease and renal control of zinc excretion. Prog Clin Biol Res. 1977;14:193–209
  11. Kinlaw WB, Levine AS, Morley JE, Silvis SE, McClain CJ. Abnormal zinc metabolism in type II diabetes mellitus. Am J Med. 1983;75:273–277
  12. Moher D, Cook DJ, Eastwood S, et al. for the QUOROM Group Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet. 1999;354:1896–1900
  13. Anderson RA, Roussel A-M, Zouari N, et al. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am Coll Nutr. 2001;20:212–218
  14. Roussel A-M, Kerkeni A, Zouari N, et al. Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J Am Coll Nutr. 2003;22:316–321
  15. Fortes C, Agabiti N, Fano V, et al. Zinc supplementation and plasma lipid peroxides in an elderly population. Eur J Clin Nutr. 1997;51:97–101
  16. Girodon F, Blache D, Monget A-L, et al. Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters. J Am Coll Nutr. 1997;16:357–365
  17. Thurnham DI, Munoz N, Lu JB, et al. Nutritional and haematological status of Chinese farmers: the influence of 13.5 months treatment with riboflavin, retinol and zinc. Eur J Clin Nutr. 1988;42:647–660
  18. Hininger-Favier I, Andriollo-Sanchez M, Arnaud J, et al. Age- and sex-dependent effects of long-term zinc supplementation on essential trace element status and lipid metabolism in European subjects: the Zenith study. Br J Nutr. 2007;97:569–578
  19. Feillet-Coudray C, Meunier N, Bayle D, et al. Effect of zinc supplementation on in vitro copper-induced oxidation of low-density lipoproteins in healthy French subjects aged 55-70 years: the Zenith study. Br J Nutr. 2006;95:1134–1142
  20. Pachotikarn C, Medeiros DM, Windham F. Effect of oral zinc supplementation upon plasma lipids, blood pressure, and other variables in young adult white males. Nutr Rep Int. 1985;32:373–381
  21. Goodwin JS, Hunt WC, Hooper P, Garry PJ. Relationship between zinc intake, physical activity, and blood levels of high-density lipoprotein cholesterol in a healthy elderly population. Metabolism. 1985;34:519–523
  22. Walldius G, Michaëlsson G, Hardell L-I, Åberg H. The effects of diet and zinc treatment on the fatty acid composition of serum lipids and adipose tissue and on serum lipoproteins in two adolescent patients with acrodermatitis enteropathica. Am J Clin Nutr. 1983;38:512–522
  23. Muskiet FAJ, Muskiet FD, Meiborg G, Schermer JG. Supplementation of patients with homozygous sickle cell disease with zinc α-tocopherol, vitamin C, soybean oil, and fish oil. Am J Clin Nutr. 1991;54:736–744
  24. Brewer GJ, Dick RD, Johnson VD, et al. Treatment of Wilson's disease with zinc XV: long-term follow-up studies. J Lab Clin Med. 1998;132:264–278
  25. Brewer GJ, Dick RD, Johnson VD, et al. Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years. J Lab Clin Med. 2001;137:191–198
  26. Song MK, Rosenthal MJ, Naliboff BD, Phanumas L, Kang KW. Effects of bovine prostate powder on zinc, glucose, and insulin metabolism in old patients with non-insulin-dependent diabetes mellitus. Metabolism. 1998;47:39–43
  27. Kies C, Joseph A, Fox HM. Blood serum lipid levels and fecal fat excretion of adult humans as affected by dietary hemicellulose and zinc. Nutr Rep Int. 1983;28:147–153
  28. Ziccarelli VE, Basu TK. An in vivo study of the antioxidant potentials of a plant food concentrate. J Am Coll Nutr. 2003;22:277–282
  29. Hunt JR, Matthys LA, Johnson LK. Zinc absorption, mineral balance, and blood lipids in women consuming controlled lactoovovegetarian and omnivorous diets for 8 wk. Am J Clin Nutr. 1998;67:421–430
  30. Milne DB, Davis CD, Nielsen FH. Low dietary zinc alters indices of copper function and status in postmenopausal women. Nutrition. 2001;17:701–708
  31. Freeland-Graves JH, Friedman BJ, Han W-H, Shorey RL, Young R. Effect of zinc supplementation on plasma high-density lipoprotein cholesterol and zinc. Am J Clin Nutr. 1982;35:988–992
  32. Crouse SF, Hooper PL, Atterbom HA, Papenfuss RL. Zinc ingestion and lipoprotein values in sedentary and endurance-trained men. JAMA. 1984;252:785–787
  33. Black MR, Medeiros DM, Brunett E, Welke R. Zinc supplements and serum lipids in young adult white males. Am J Clin Nutr. 1988;47:970–975
  34. Bogden JD, Oleske JM, Lavenhar MA, et al. Zinc and immunocompetence in elderly people: effects of zinc supplementation for 3 months. Am J Clin Nutr. 1988;48:655–663
  35. Samman S, Roberts DCK. The effect of zinc supplements on lipoproteins and copper status. Atherosclerosis. 1988;70:247–252
  36. Shah DR, Singh PP, Gupta RC, Bhandari TK. Effect of oral zinc sulphate on serum lipids and lipoproteins in human subjects. Indian J Physiol Pharmacol. 1988;32:47–50
  37. Boukaiba N, Flament C, Acher S, et al. A physiological amount of zinc supplementation: effects on nutritional, lipid, and thymic status in an elderly population. Am J Clin Nutr. 1993;57:566–572
  38. Bogden JD, Bendich A, Kemp FW, et al. Daily micronutrient supplements enhance delayed-hypersensitivity skin test responses in older people. Am J Clin Nutr. 1994;60:437–447
  39. Gatto LM, Samman S. The effect of zinc supplementation on plasma lipids and low-density lipoprotein oxidation in males. Free Radical Biol Med. 1995;19:517–521
  40. Federico A, Iodice P, Federico P, et al. Effects of selenium and zinc supplementation on nutritional status in patients with cancer of digestive tract. Eur J Clin Nutr. 2001;55:293–297
  41. The Age-Related Eye Disease Study (AREDS) Research Group. The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the Age-Related Eye Disease study: AREDS Report No. 7. J Nutr 2002; 132: 697–702.
  42. Chevalier CA, Liepa G, Murphy MD, et al. Effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients. J Ren Nutr. 2002;12:183–189
  43. Bonham M, O’Connor JM, McAnena LB, et al. Zinc supplementation has no effect on lipoprotein metabolism, hemostasis, and putative indices of copper status in healthy men. Biol Trace Elem Res. 2003;93:75–86
  44. Farvid MS, Siassi F, Jalali M, Hosseini M, Saadat N. The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes. Diabetes Res Clin Pract. 2004;65:21–28
  45. Hercberg S, Bertrais S, Czernichow S, et al. Alterations of the lipid profile after 7.5 years of low-dose supplementation in the SU.VI.MAX study. Lipids. 2005;40:335–342
  46. Kadhim HM, Ismail SH, Hussein KI, et al. Effects of melatonin and zinc on lipid profile and renal function in type 2 diabetic patients poorly controlled with metformin. J Pineal Res. 2006;41:189–193
  47. Partida-Hernandez G, Arreola F, Fenton B, et al. Effect of zinc replacement on lipids and lipoproteins in type 2-diabetic patients. Biomed Pharmacother. 2006;60:161–168
  48. Afkhami-Ardekani M, Karimi M, Mohammadi SM, Nourani F. Effect of zinc supplementation on lipid and glucose in type 2 diabetic patients. Pak J Nutr. 2008;7:550–553
  49. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  50. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008). The Cochrane Collaboration, 2008. http://cochrane-handbook.org.
  51. In:  Glasziou P,  Irwig L,  Bain C,  Colditz G editor. Systematic Reviews In Health Care: A Practical Guide. Cambridge: Cambridge University Press; 2001;
  52. Klevay LM, Pond WG, Medeiros DM. Decreased high-density lipoprotein cholesterol and apoprotein A-I in plasma and ultrastructural pathology in cardiac muscle of young pigs fed a diet high in zinc. Nutr Res. 1994;14:1227–1239
  53. Wu JYJ, Wu Y, Reaves SK, et al. Apolipoprotein A-I gene expression is regulated by cellular zinc status in Hep G2 cells. Am J Physiol Cell Physiol. 1999;277:537–544
  54. Wu JY, Reaves SK, Wang YR, et al. Zinc deficiency decreases plasma level and hepatic mRNA abundance of apolipoprotein A-I in rats and hamsters. Am J Physiol. 1998;275:C1516–C1525
  55. Samman S. Dietary versus cellular zinc: the antioxidant paradox. Free Radical Biol Med. 1993;14:95–96
  56. Klevay LM, Inman L, Johnson LK, et al. Increased cholesterol in plasma in a young man during experimental copper depletion. Metabolism. 1984;33:1112–1118
  57. Valsala P, Kurup PA. Investigations on the mechanism of hypercholesterolemia observed in copper deficiency in rats. J Biosci. 1987;12:137–142
  58. Yount NY, Carr TP, McNamara DJ, Lei KY. Incorporation of tritiated water into sterol in copper-deficient rats. Biochim Biophys Acta. 1991;1082:79–84
  59. Zavaroni I, Dall’Aglio E, Bruschi OAF, et al. Evidence for an independent relationship between plasma insulin and concentration of high-density lipoprotein cholesterol and triglyceride. Atherosclerosis. 1985;55:259–266
  60. Chimienti F, Devergnas S, Pattou F, et al. In vivo expression and functional characterisation of the zinc transporter ZnT8 in glucose-induced insulin secretion. J Cell Sci. 2006;119:4199–4206
  61. Taylor CG. Zinc, the pancreas, and diabetes: Insights from rodent studies and future directions. Biometals. 2005;18:305–312
  62. Chausmer AB. Zinc, insulin and diabetes. J Am Coll Nutr. 1998;17:109–115
  63. Kirchhoff K, Machicao F, Haupt A, et al. Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia. 2008;51:597–601
  64. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445:881–885
  65. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical ResearchSaxena R, Voight BF, Lyssenko V, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007;316:1331–1336
  66. Soinio M, Marniemi J, Laakso M, et al., Pyorala K, Lehto S, Ronnemaa T Serum zinc level and coronary heart disease events in patients with type 2 diabetes. Diabetes Care. 2007;30:523–528
  67. Samman S, Zinc copper. In:  Mann JI,  Truswell AS editor. Essentials of Human Nutrition.. 3rd ed.. New York: Oxford University Press; 2007;p. 138–144
  68. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79:8–15

PII: S0021-9150(09)00995-2

doi: 10.1016/j.atherosclerosis.2009.11.038

Atherosclerosis
Volume 210, Issue 2 , Pages 344-352 , June 2010

Article Tools

* Image Usage & Resolution